Citicoline & Antioxidants in Glaucoma

Status Completed

Clinical Trial Summary

To evaluate the long-term effects of oral citicoline, vitamins A, B, C and E, and blackcurrant therapy in patients with primary open-angle glaucoma (POAG) using optical coherence tomography (OCT), OCT angiography (OCTA) and microperimetry parameters.

Clinical Trial Description

AIMS: To evaluate the long-term effects of oral citicoline, vitamins A, B, C and E, and blackcurrant therapy in patients with primary open-angle glaucoma (POAG) using optical coherence tomography (OCT), OCT angiography (OCTA) and microperimetry parameters. METHODS: Fifteen patients with POAG (treated group) received one soluble liquid sachet daily for 20 days a month of a complementary dietary supplement containing in fixed combination citicoline, vitamins A, B, C, and E, and blackcurrant for 1 year. Fifteen age-matched subjects affected by POAG were given a placebo and served as a control group. The patients underwent best corrected visual acuity (BCVA), Goldmann applanation tonometry, microperimetry examination, OCT, and OCTA at the beginning of the study and then at 1, 6 and 12 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06355765
Study type	Observational [Patient Registry]
Source	University of Naples
Contact
Status	Completed
Phase
Start date	January 10, 2022
Completion date	December 10, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05044793` - A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
Recruiting	`NCT06201455` - Evaluation of Phacogoniotomy in Medically-controlled POAG	N/A
Recruiting	`NCT03369886` - The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI	N/A
Active, not recruiting	`NCT04624698` - iStent Inject New Enrollment Post-Approval Study	N/A
Recruiting	`NCT02679482` - Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma	N/A
Completed	`NCT02338362` - Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma	Phase 4
Active, not recruiting	`NCT01430923` - Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost	N/A
Completed	`NCT01489670` - Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension	N/A
Completed	`NCT00753168` - Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma	Phase 1/Phase 2
Completed	`NCT00693485` - Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy	Phase 2
Completed	`NCT00051194` - A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension	Phase 2
Recruiting	`NCT04920227` - Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma	N/A
Active, not recruiting	`NCT03868124` - Clinical Study Comparing Two Models of a Travoprost Intraocular Implant	Phase 3
Completed	`NCT03267862` - Scleral Response to Intraocular Pressure (IOP)	N/A
Recruiting	`NCT06066645` - Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone	Phase 3
Recruiting	`NCT04912362` - The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma	N/A
Completed	`NCT04949802` - Glaucoma Surgery Using the ViaLase Laser System	N/A
Recruiting	`NCT04038034` - Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma	N/A
Completed	`NCT04632329` - Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma	N/A
Completed	`NCT01215786` - Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma	Phase 1